Health
Metformin treatment linked to slowed cognitive decline – EurekAlert
A six-year study of older Australians with type 2 diabetes has uncovered a link between metformin use, slower cognitive decline and lower dementia rates.
Metformin is the first-line treatment for most cases of type 2 diabetes and one of the most commonly prescribed medications worldwide, with millions of individuals using it to optimise their blood glucose levels.
A new research study, conducted over six years in the Sydney Memory and Ageing Study in 1037 Australians (aged 70 to 90 years old at baseline), has revealed an additional effect: individuals with type 2 diabetes who used metformin experienced slower cognitive decline with lower dement…
-
Business15 hours agoThese 4 ASX mining stocks are rocketing as the rare earths boom intensifies
-
General12 hours agoBunbury man Stanley J Clemons sentenced for shooting neighbour’s dog
-
General22 hours agoAustralia solved civilisation’s problems
-
Business20 hours agoThis artificial intelligence (AI) stock will be the Nvidia of quantum computing by 2035